TFFP - יחס חוב להיוון בספרים TFF Pharmaceuticals Inc.

TFF Pharmaceuticals (TFFP) is currently executing a hard pivot, cutting costs and seeking to license its thin-film drying technology. Analyzing the chart on GURU.Markets, we see that the company's total debt-to-equity ratio currently stands at 0.02. The company is also developing inhalation powders through biolabs and creating dry vaccine formulations in collaboration with external drug developers.

A defensive portfolio requires strict monitoring of the issuer's financial stability. This indicator compares total liabilities to the book value of equity to determine the business's degree of dependence on borrowed funds. For TFF Pharmaceuticals (TFFP), this balance is critical when implementing automated thin-film freezing lines. A high debt load could limit the scaling of robotic production. The trend in the total debt-to-book capitalization ratio reflects the company's current margin of safety.